InvestorsHub Logo
Followers 26
Posts 1372
Boards Moderated 0
Alias Born 01/18/2011

Re: ospreyeye post# 45772

Tuesday, 10/14/2014 12:03:30 PM

Tuesday, October 14, 2014 12:03:30 PM

Post# of 182989
$SRPT Oppenheimer Maintains Outperform On Sarepta As 3-Year Data Support Eteplirsen's Clinical Benefit http://www.smarteranalyst.com/2014/10/14/oppenheimer-maintains-outperform-sarepta-3-year-data-support-eteplirsens-clinical-benefit/

Here's another one..
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.